Skip to content

HEMODELVA

Active Private limited companyfounded 2010active for 16 yearsRue de Hal 48, 1421 Braine-l'AlleudKBO/BCE: BE 0823.602.353

Lifetime

16 annual accounts with figures on one time axis
peak of €110,883 in 2025
€87,914▼ 20.7%
lowest -€28,089 in 2021
€42,559▼ 34.6%
peak of €167,054 in 2026
€167,054▲ 34.2%
€158,885▼ 9.2%
Board1 name since 2010
1 director
Owners
  
Documentsfilings and deeds
17-11-202617 days late
2026micro format
Gross margin from €110,883 to €87,914Result from €65,029 to €42,559Equity from €124,494 to €167,054

Key points

from the 2026 annual accounts

Equity

€167,054 ▲ 34.2%

HEMODELVA has made a profit without a break since 2023.

Turnover

≈ €260,000 estimated

The micro format states no turnover.

Filings

16 annual accounts since 2011
deadline201520202025

Two of the last ten came late. The 2026 accounts came in latest, 17 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,724 companies had the same profile as HEMODELVA has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,724 companies, not a prediction for HEMODELVA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • 100%annual accounts 31-03-2018
Board & ownership

Recent changes

Purpose change · Amendment of the articles · Legal-form change · Resignations & appointments “La médecine est exercée, par chaque médecin-associé, au nom et pour le compte de la société; La responsabilité…” (deed in French) · General meeting of 06-05-2022 · Gazette deed
Registered office moved from Brussels to Ophain-Bois-Seigneur-Isaac The registered office moved from Saint-Gilles (1060 Bruxelles), rue Antoine Bréart, 67/3 to rue du Hal 48, 1421 Ophain-Bois-Seigneur-Isaac · Gazette deed
Incorporation Founding capital of €18,600, 100 shares, €12,400 paid up · Founded by · appointed as manager · published on 05-03-2010 · Gazette deed
All 29 events

Official details

Source: KBO
Status
Active since 03-03-2010Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 7 activities
Establishment unit
2.187.317.5341060 Sint-Gillis (bij-Brussel), since 28-04-2010
Financial year end
31 March
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 31-03-2026

€325,939▲ 8.8%
Filing
Filed on 17-11-2026
Financials

Insights on HEMODELVA

HEMODELVA files the micro format. That format states no turnover. The gross margin rose from €29,712 in 2011 to €87,914 in 2026.

The balance sheet grew most from 2012 to 2014 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about HEMODELVA

What is the company number of HEMODELVA?
The company number of HEMODELVA is 0823.602.353. The VAT number is the same number with BE in front: BE 0823.602.353.
Where is HEMODELVA based?
The registered office is at Rue de Hal 48, 1421 Braine-l'Alleud.Company details
What does HEMODELVA do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of HEMODELVA?
HEMODELVA is a private limited company (BV).
When was HEMODELVA founded?
HEMODELVA was founded on 03-03-2010.
Is HEMODELVA still active?
Yes, HEMODELVA is an active enterprise in the KBO register.
What is the turnover of HEMODELVA?
The turnover in financial year 2026 is about €260,000. This figure is estimated from the gross margin of €87,914 and 2,989 comparable companies of the same size. It probably lies between €170,000 and €450,000. It is a rough estimate.Financials
Is HEMODELVA profitable?
In financial year 2026, HEMODELVA made a profit of €42,559.
Where can I find the annual accounts of HEMODELVA?
HEMODELVA filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of HEMODELVA due?
HEMODELVA must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.